Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BioClinica ApS
APS
In liquidation
CVR 41590939
Pilestræde 58, 1112
København K
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 5 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BioClinica ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (9)
CO
Christopher Orlando
Management
Management
2020 – 2022
CR
Charles R Bodner
Management
Management
2020 – 2022
TP
Thomas Patrick Stuckey
Management
Management
2023 – 2025
NL
Niels Løber
Unofficial title
Unofficial title
2025 – 2026
TA
Timothy Alan Cobb
Management
Management
2024 – 2025
MW
Maureen Waters Marchek
Management
Management
2020 – 2023
MJ
Michael John Bonello
Management
Management
2022 – 2023
DS
Daniel Scott Braem
Chief Executive Officer
Chief Executive Officer
2023 – 2024
MR
Michael Richard Sandusky
Management
Management
2024 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
BIOCLINICA, INC.
Individual
100%
100%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BioClinica ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
